Cas9-AAV6-engineered human mesenchymal stromal cells improved cutaneous wound healing in diabetic mice
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cas9-AAV6-engineered human mesenchymal stromal cells improved cutaneous wound healing in diabetic mice
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-18
DOI
10.1038/s41467-020-16065-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility
- (2019) Huaigeng Xu et al. Cell Stem Cell
- Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34 + Hematopoietic Stem and Progenitor Cells
- (2018) M. Kyle Cromer et al. MOLECULAR THERAPY
- Priming Human Repopulating Hematopoietic Stem and Progenitor Cells for Cas9/sgRNA Gene Targeting
- (2018) Carsten T. Charlesworth et al. Molecular Therapy-Nucleic Acids
- Reprogramming human T cell function and specificity with non-viral genome targeting
- (2018) Theodore L. Roth et al. NATURE
- A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
- (2018) Christopher A. Vakulskas et al. NATURE MEDICINE
- Efficient homology-directed gene editing by CRISPR/Cas9 in human stem and primary cells using tube electroporation
- (2018) Xiaoyun Xu et al. Scientific Reports
- Diabetes and Wound Angiogenesis
- (2017) Uzoagu Okonkwo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors
- (2017) Rasmus O. Bak et al. Cell Reports
- Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6
- (2017) Rasmus O Bak et al. eLife
- Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial
- (2016) Julián Panés et al. LANCET
- CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
- (2016) Daniel P. Dever et al. NATURE
- Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells
- (2016) M. A. DeWitt et al. Science Translational Medicine
- MSCs: The Sentinel and Safe-Guards of Injury
- (2015) Arnold I. Caplan JOURNAL OF CELLULAR PHYSIOLOGY
- Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
- (2015) Ayal Hendel et al. NATURE BIOTECHNOLOGY
- Development and Applications of CRISPR-Cas9 for Genome Engineering
- (2014) Patrick D. Hsu et al. CELL
- MSC-Based Product Characterization for Clinical Trials: An FDA Perspective
- (2014) Michael Mendicino et al. Cell Stem Cell
- Mesenchymal stem cells: immune evasive, not immune privileged
- (2014) James A Ankrum et al. NATURE BIOTECHNOLOGY
- Easy quantitative assessment of genome editing by sequence trace decomposition
- (2014) Eva K. Brinkman et al. NUCLEIC ACIDS RESEARCH
- Genome Editing of Mouse Fibroblasts by Homologous Recombination for Sustained Secretion of PDGF-B and Augmentation of Wound Healing
- (2014) Jenny C. Barker et al. PLASTIC AND RECONSTRUCTIVE SURGERY
- Wound healing: an update
- (2014) Elizabeth R Zielins et al. Regenerative Medicine
- Wound repair and regeneration: Mechanisms, signaling, and translation
- (2014) S. A. Eming et al. Science Translational Medicine
- mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation
- (2013) O. Levy et al. BLOOD
- DNA targeting specificity of RNA-guided Cas9 nucleases
- (2013) Patrick D Hsu et al. NATURE BIOTECHNOLOGY
- CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity
- (2013) Thomas J. Cradick et al. NUCLEIC ACIDS RESEARCH
- Histone Deacetylase Inhibition Activates Transgene Expression from Integration-Defective Lentiviral Vectors in Dividing and Non-Dividing Cells
- (2012) Laetitia P.L. Pelascini et al. HUMAN GENE THERAPY
- Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials
- (2012) Manoj M. Lalu et al. PLoS One
- Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long-Term Engraftment and No Ectopic Tissue Formation
- (2012) L. von Bahr et al. STEM CELLS
- Therapeutic potential of bone marrow-derived mesenchymal stem cells for cutaneous wound healing
- (2012) Jerry S. Chen et al. Frontiers in Immunology
- Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: A double-blind, randomized, controlled trial
- (2011) Debin Lu et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Human MSC Suppression Correlates With Cytokine Induction of Indoleamine 2,3-Dioxygenase and Bystander M2 Macrophage Differentiation
- (2011) Moïra François et al. MOLECULAR THERAPY
- Targeted gene addition to human mesenchymal stromal cells as a cell-based plasma-soluble protein delivery platform
- (2010) Basma F. Benabdallah et al. CYTOTHERAPY
- Defining the risks of mesenchymal stromal cell therapy
- (2010) Darwin J. Prockop et al. CYTOTHERAPY
- Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
- (2008) Salima Hacein-Bey-Abina et al. JOURNAL OF CLINICAL INVESTIGATION
- Wound repair and regeneration
- (2008) Geoffrey C. Gurtner et al. NATURE
- Mesenchymal Stem Cells – Sources and Clinical Applications
- (2008) Hans Klingemann et al. TRANSFUSION MEDICINE AND HEMOTHERAPY
- PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing
- (2008) Stephan Barrientos et al. WOUND REPAIR AND REGENERATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now